Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2011-01-18
2011-01-18
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S182000
Reexamination Certificate
active
07871994
ABSTRACT:
Method for hormone replacement therapy, in which at least in the established postmenopause a daily unit with at least one hormonal component, namely with at least estrogen (E) and/or at least one gestagen (G) is administered permanently and continuously every day, characterized in that in at least one ingestion period preceding the permanent administration of hormone daily units is provided an ingestion pause (P), in which either no daily units or placebos or daily units with a much lower estrogen and/or gestagen content than during the permanent administration of hormone daily units in the established postmenopause and during the ingestion phase(s) of the preceding ingestion period are administered, as well as administration form for hormone therapy.
REFERENCES:
patent: RE36247 (1999-07-01), Plunkett et al.
patent: 5980940 (1999-11-01), Spona et al.
patent: 19539233 (1997-04-01), None
patent: WO 94/02103 (1994-02-01), None
patent: WO 95/22332 (1995-07-01), None
patent: WO 95/22334 (1995-07-01), None
Teather et al., Journal of Bacteriology, 1990;172(7):3837-3841.
Martindale: 1993, Pharm. Press, London XP002229615, p. 1169-1170.
Bayer Schering Pharma AG
Hui San-ming
Millen White Zelano & Branigan P.C.
LandOfFree
Hormone replacement therapy method and its administration form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hormone replacement therapy method and its administration form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hormone replacement therapy method and its administration form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2736263